Week In Review: Week's China Life Science Investments Total $800 Million

Harbour BioMed completed a $221 million Hong Kong IPO to continue its novel drug development. Singlera Genomics, a San Diego-Shanghai genomics testing company, closed a $150 million Series B financing from China investors.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.